Olga Tsiamita/LinkedIn
Oct 15, 2025, 06:53
Olga Tsiamita Publishes Study on Duffy Null Neutrophil Count and Trial Inclusivity
Olga Tsiamita, Haematology SpR at Barts Health NHS Trust, posted on LinkedIn:
”Proud to share our paper on Medical haematology trial eligibility and the Duffy null‐associated neutrophil count.
We need to keep moving towards improving inclusivity in clinical trials.”
Read the full article here.
Title: Medical haematology trial eligibility and the Duffy null‐associated neutrophil count: A cross‐sectional study
Authors: Olga Tsiamita, Laura Aiken, Mohsin Badat, Gill Lowe, Funmi Oyesanya, Sonia Wolf, Lauren E Merz, Andrew Hantel, Stephen P Hibbs
Stay updated with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine